Figure 5
From: Clinical outcomes of self-expandable metallic stents for malignant obstructive atelectasis
Survival follow-up. The survival rates of 3 months, 1 year and 2 years were 78.6%, 58.5% and 58.5%, respectively.
Figure 5 | Scientific Reports
From: Clinical outcomes of self-expandable metallic stents for malignant obstructive atelectasis
Survival follow-up. The survival rates of 3 months, 1 year and 2 years were 78.6%, 58.5% and 58.5%, respectively.
